Accueil > Actualité
Actualite financiere : Actualite bourse

J&J: eye gene therapy shows encouraging results

(CercleFinance.com) - Johnson & Johnson's pharmaceutical unit Janssen said that its gene therapy has showed promising results in an early-stage clinical trial on patients with inherited retinal disease X-linked retinitis pigmentosa (XLRP).


According to six-month data from an ongoing Phase 1/2 trial, low and intermediate doses of the experimental product were generally well-tolerated and resulted in a significant improvement in vision.

In patients with XLRP, the photoreceptors in the eye - which are responsible for converting light into signals that are sent to the brain - function poorly, leading to degeneration of the retina and blindness.

There are currently no approved treatments for this condition.

Copyright (c) 2020 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.